
|Articles|November 4, 2016
PCSK9 Inhibitor Development Stoppage Highlights Week in Specialty Pharmacy
Author(s)Davy James, Managing Editor
Top articles of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/pcsk9-inhibitor-development-stoppage-highlights-we" target="_blank">View the story "PCSK9 Inhibitor Development Stoppage Highlights Week in Specialty Pharmacy" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
How Pharmacists Can Close the Opioid Addiction Care Gap
2
US Measles Cases Climb, Raising Questions About Preparedness and Prevention
3
FDA Awards National Priority Voucher to Teclistamab Plus Daratumumab in Relapsed/Refractory Multiple Myeloma
4
The Return of Belantamab Mafodotin: Past Lessons, Present Promise, and Future Impact
5
















































































































































































































